REG - Iconic Labs PLC - Subscription of Convertible Notes

Iconic LabsAnnouncement

22/03/2023 12:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230322:nRSV8807Ta&default-theme=true

RNS Number : 8807T  Iconic Labs PLC  22 March 2023

 

Iconic Labs PLC

 

("Iconic" or the "Company")

 

 

EHGOSF Subscribes for a £150,000 Fifth Tranche Under £ 3million Financing
Facility

 

Iconic Labs PLC (LSE: ICON) announces that. the European High Growth
Opportunities Securitization Fund ("EHGOSF") has subscribed for a £150,000
fifth tranche of convertible notes under the £3million financing facility
(the "Facility") that was entered into on 28 September 2022. This subscription
takes the total subscribed under the Facility to £850,000.

 

In exchange, Iconic will issue 150 convertible notes to EHGOSF along with
1,250,000,000 warrants with an exercise price of £0.00006.

 

The funds under this fifth tranche shall be used to meet Iconic's obligations
under the CVA and for operational purposes.

 

This announcement contains inside information for the purposes of Article 7 of
the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic
law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is
disclosed in accordance with the Company's obligations under Article 17 of
MAR.

 

For any further information or enquiries please contact:

 

ir@iconiclabs.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCPPUQCWUPWGGP